Home › Smoking and Youth › NCT06926608
Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Self-identify as Hispanic and/or Latino * Know how to read and speak English and/or Spanish * Be ≥ 18 years of age * Not meet the recommended levels of physical activity (150 minutes of moderate to vigorous physical activity) * Smoke cigarettes at least 3 days per week * Be interested in quitting smoking in the next 30 days * Have a cellphone with text messaging capability * Know how to utilize text messages * Be willing to wear a wearable device daily to monitor physical activity * Be willing to complete all study visits Exclusion Criteria: * Use of tobacco products other than cigarettes in the past 30 days (including e-cigarettes) * Being pregnant or breastfeeding * Plan to move from their current residence in the next six months * Another household member enrolled in the study * Unable to become more physically active or engage in a fitness appraisal
About the study
The purpose of this randomized controlled trial is to assess the efficacy of Actívatexto (Aim 1) and the mediators of the presumed treatment effect (Aim 2) among Latino adults who smoke. Actívatexto is a mobile intervention that integrates four components: 1) a text messaging program that promotes both smoking cessation and physical activity, 2) wearable devices to monitor physical activity, 3) smoking cessation pharmacotherapy \[i.e., nicotine replacement therapies (NRT)\], and 4) an online dashboard where the research team manages participants' incoming and outgoing data from both the text messaging program and wearable devices.
What is being tested
- Actívatexto (behavioral)
- Decídetexto (behavioral)
Sponsor: University of Rochester · Participants: 408 · Started: Jun 17, 2025
Contact the study team
- Francisco Cartujano, MD · Phone: (585) 273-1646
Official record on ClinicalTrials.gov — NCT06926608
Locations in the U.S.
| New York | University of Rochester Medical Center, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.